According to AdvaMed, a medical device lobbying group, the average prices paid for medical devices declined from 2007 to 2011 on an inflation-adjusted basis.
Covidien (COV) announced that it will lay off a significant amount of employees as part of global restructuring efforts. The initiative aims to save the company up to $300 million a year by fiscal 2018.
The expansion of the CMS competitive bidding system will put additional pressure on device manufacturers trying to stay in business in the wake of Obamacare.
Why Asian market growth for diagnostic imaging devices is seeing its greatest rate in history—greater than any other region of the globe.
The upward trends of the healthcare market show that Brazil is positive for the medical device industry, suggesting rapid increases in demand as more and more people can afford the devices and pay accordingly.
Brazil is the largest market for medical devices in South America. This year, the market is expected to reach $8 billion in revenue.
Most large U.S. manufacturers have invested significant capital into emerging markets, including Medtronics, Johnson & Johnson, GE, and Stryker.
Espicom Business Intelligence forecasts the Israeli market to be valued at $1.096 billion in 2016—a 20% increase over five years. The country looks to the medical device industry for a significant amount of growth.
Regulators in China have begun working on new standards to better control the domestic production of medical devices.
Medtronic has always been considered a bellwether for the medical device industry because of its pure focus on the device market. Yet that changed in mid-August, as Medtronic announced its acquisition of Cardiocom.
Adjusting performance on a risk basis As new insurees flood the insurance market and baby boomers approach retirement, the healthcare space should expect dramatic increases in demand. Alongside an increase…
What is a Sharpe ratio? A Sharpe ratio is a tool that measures the amount of returns for each unit of volatility that’s generated by a portfolio (higher returns and…
Big change to come in the healthcare industry Ready or not, state-run insurance exchanges will be ready for open enrollment starting October 1. The introduction of these public exchanges for…
The proposed Protect Medical Innovation Act of 2013 The Protect Medical Innovation Act of 2013 has gained bi-partisan support in the House of Representatives, ensuring the bill passes when it…
Healthcare stocks are performing strongly Healthcare stocks have been among top Wall Street performers this year, and their momentum isn’t looking to subside anytime soon as the industry evolves with…
Develops pharmaceuticals drugs for treatment of central nervous system disorders
Operates as a holding company with interest in manufacturing pharmaceutical products
Operates as a biopharmaceutical company which focuses on therapies for patients with renal disease
Engages in discovery, development and commercialization of novel biotherapeutics